cancer cell impact factor - Yahoo Search Results

Search results

- Luton man treated for breast cancer given 'wonder drug'
  BBC News· 8 hours ago
  A man who was given "a wonder drug" to target his stage four cancer said it was "like an oasis in...
- Why breast cancer recurrence rates are higher in Black women
  Rolling Out· 7 days ago
  Breast cancer is a pervasive health concern that affects women globally, but its impact varies...
- An automated approach to saving lives
  Fast Company Magazine· 5 days ago
  For patients with serious ailments—ranging from cancer to autoimmune diseases—access to cell therapies can mean the difference between life and death....
- Lung cancer: Pre- and postsurgical immunotherapy may improve outcomes
  Medical News Today· 6 days ago
  Lung cancer is a major cause of all cancer-related deaths, with some treatment options involving...
- Study finds significant disparities in the delivery of cancer-related care
  Medical Xpress· 6 hours ago
  It's important to ensure that care provided at US hospitals that predominantly serve Black and...
- Study identifies differences in prostate cancer genomics among a racially and ethnically diverse...
  Medical Xpress· 3 days ago
  After adjusting for a number of individual patient-level factors, including the type of cancer...
- Can diet help with advanced breast cancer? All indications are positive, researchers say
  Medical Xpress· 5 days ago
  The outcomes are from a small study by researchers at the University of Rochester Medical Center and...
- Study investigates whether Weo electrolyzed water can modulate phenotype of senescent cells
  Medical Xpress· 5 days ago
  A new research paper titled "Cell type-dependent modulation of senescence features using Weo electrolyzed water" has been published in Aging.
- BioLineRx reports positive pancreatic cancer trial results By Investing.com
  Investing.com· 3 days ago
  (NASDAQ: BLRX), a biopharmaceutical company, announced encouraging results from the pilot phase of...
- Small Business - The Brewton Standard | The Brewton Standard
  The Brewton Standard· 4 days ago
  Blueprint Medicines to Present the First Promising and Most Advanced Clinical Data for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer< ...